Eastman Kodak(US:KODK)2025-03-17 22:42Financial Performance - Q4 2024 - Revenue decreased by $9 million, a 3% decline, from $275 million in Q4 2023 to $266 million[10, 13] - Gross profit increased by $4 million, a 9% improvement, from $47 million in Q4 2023 to $51 million[13] - Net income significantly increased by $21 million, a 420% jump, from $5 million in Q4 2023 to $26 million[13] - Operational EBITDA increased by $7 million, a 350% rise, from $2 million in Q4 2023 to $9 million[13] Financial Performance - Full Year 2024 - Revenue decreased by $74 million, a 7% decline, from $1.117 billion in 2023 to $1.043 billion[10, 15] - Net income increased by $27 million, a 36% rise, from $75 million in 2023 to $102 million[15] - Operational EBITDA decreased by $19 million, a 42% decline, from $45 million in 2023 to $26 million[15] Strategic Initiatives and Investments - Kodak approved the termination of the Kodak Retirement Income Plan effective March 31, 2025, expecting reverted assets to reduce long-term debt[12] - Continued investment in film manufacturing to increase capacity and modernize the plant[10] - Ongoing investment in the build-out of a Current Good Manufacturing Practice ("cGMP") pharma facility, scheduled for production in 2025[10]